Подпишитесь на нашу рассылку, чтобы быть в курсе последних событий
Нажмите здесь
  • BLS
  • Spotlight

Safety guide: chemical pharmaceutical industry

BLS Safety Guide: chemical-pharmaceutical industry


A guide written by Dr. Antonio Moffa, Dr. Claudia Beccaria and Lucrezia Giorgi of the Unit of Integrated Therapies in Otolaryngology at the University Polyclinic Campus Bio-Medical Foundation in Rome.

 

The manufacture of pharmaceutical products involves the use of numerous chemicals, obtained by fermentation, organic or biological synthesis, which can sometimes be used in very high concentrations and risk endangering the health or safety of operators.

 

 

The handling of chemical or biological substances used in drugs and reagents involves acute and chronic risks. The toxic effects, such as mutagenesis and neurotoxicity, are often irreversible and may persist over time. The most commonly used products include solvents, corrosive acids and caustic bases. It is essential to manage these risks to ensure the safety of operators and the public.

Granulating, mixing and wet coating operations can expose operators to high solvent vapours. During other steps such as distribution, drying and mixing, airborne particles may increase exposure. The handling and storage of these products pose risks of exposure through inhalation, ingestion or direct contact during plant breakdowns. These risks must be carefully managed to prevent harmful exposures and related diseases. Below are the risks related to the various work steps of toxic products and associated diseases. (see table)

 

 

Toxicity risks depend on the physical and chemical properties of the products and the routes of entry into the body. Workers in pharmaceutical industries may be exposed to chemicals through inhalation, skin contact, ingestion and eye projection. Common occupational diseases in the industry include osteomuscular, respiratory, ear problems, tumours and other diseases. Exposures to dust, gaseous compounds and solvent vapours can cause allergic reactions, respiratory disorders and cancers. The substances most frequently implicated as causes of occupational diseases include asbestos, hydrocarbon derivatives and other specific chemicals.

 

 

In pharmaceutical industries, risk prevention is based on a number of collective and individual measures. Collective measures include adequate infrastructure such as well-designed rooms, safe work plans and effective ventilation devices to capture pollutants. Automation of operations through remote-controlled and controlled systems reduces the risk of operator exposure. In addition, hygienic equipment such as safety showers and eye wash stations are essential, along with hygienic practices such as hand washing.

 

In order to protect operators from chemical hazards arising from pharmaceuticals, excipients, solvents and disinfectants, the use of personal protective equipment is required. These include:

- Hand protectors, protecting against chemicals, heat, frost and potential allergens.
- Eye and face protectors, protecting against splashes, drops, dusts and irritating gases.
- Body protectors, especially in case of exposure to corrosive substances.
- Respiratory devices, protecting against the harmful effects of gases, vapours, dusts, fibres, fumes and mists.

Furthermore, it is essential that operators receive training and detailed information on the risks associated with the products and materials used, so that they can adopt safe behaviour while working.

 

Recommended products:

 

 

 

Stay informed
Stay safe.

 

Статьи по Теме

Сентябрь 29, 2022 Yamaha VR46 | The Master Camp

Conosci il progetto Yamaha VR46 Master Camp? Tavullia, Italia Oggi alla sua 10^ edizione, The Master Camp è una iniziativa nata nel 2016 da Yamaha e VR46 Academy per far crescere nuovi talenti nel motociclismo. VR46 Racing Team è la squadra di motomondiale nata da Valentino Rossi per far emergere e valorizzare le giovani promesse […]

Link
Октябрь 16, 2023 BLS 2000

BLS 2000: in arrivo la nuova maschera intera BLS amplia la propria gamma prodotti con una maschera inedita che garantisce un nuovo livello di comfort e protezione.     La nuova maschera intera BLS 2000 sta arrivando. La BLS 2000 presenta una  connessione standardizzata (secondo la normativa EN 148-1), universale per i dispositivi di protezione respiratoria. […]

Link
Октябрь 26, 2023 BLS Multi Fit System concept

Il concetto BLS di Multi Fit System Esperienza progettuale, costante innovazione, rispetto delle norme e degli standard qualitativi e attenzione alla sensibilizzazione e alla formazione contribuiscono all’offerta di prodotti sempre più vicini alle esigenze degli utilizzatori. Per molto tempo i produttori di DPI hanno convogliato i loro sforzi nella creazione di dispositivi “universali”, in modo […]

Link

Подпишитесь на рассылку новостей

Получайте информацию о наших мероприятиях, новых изделиях, каталогах и предстоящих мероприятиях.
Подписаться

Свяжитесь с нами

Обращайтесь к нам с любыми вопросами, мы ответим в течение 48 часов.
Запросить информацию

BLS S.R.L.
Società a Socio Unico
via dei Giovi, 41 - 20032 Cormano (MI) - Italia
t/f +39 02 39310212 / 66200473
info@blsgroup.it
Privacy Policy - Cookie Policy

Юридический адрес
via dei Giovi, 41 – 20032 Cormano (MI) - Italia
Capitale Sociale | Share Capital: Euro 600.000,00 i.v.
C.C.I.A.A. - R.E.A.: MI 1186898
Partita IVA | VAT N°: IT12296780153
C.F. e Iscrizione al Registro delle Imprese di Milano: 07822320151

BLS IBERIA / Av. Pau Casals, 8 08182 Sant Feliu de Codines Barcelona - Spain
BLS NORTHWEST / Reeweg, 132 3343 AP H.I. Ambacht Rotterdam - The Netherlands
BLS DO BRASIL / Rua Alvarenga Peixoto, 307 05095-010 Sao Paulo - SP - Brazil
BLS GERMANY / Steindeich 1a, 25377 Kollmar - Germany
BLS FRANCE / 18 Porte du Grand Lyon 01700 Neyron - France

crossmenuchevron-downcross-circle
RU